Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Saturday morning. The firm issued a hold rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS opened at $0.95 on Friday. Milestone Scientific has a 52-week low of $0.58 and a 52-week high of $1.39. The firm has a market cap of $74.46 million, a price-to-earnings ratio of -13.57 and a beta of 0.93. The business’s fifty day moving average is $0.96 and its 200-day moving average is $0.97.

Hedge Funds Weigh In On Milestone Scientific

A number of institutional investors have recently added to or reduced their stakes in MLSS. XTX Topco Ltd grew its holdings in Milestone Scientific by 99.2% during the 1st quarter. XTX Topco Ltd now owns 34,135 shares of the company’s stock worth $32,000 after acquiring an additional 17,002 shares during the last quarter. Brookwood Investment Group LLC bought a new stake in Milestone Scientific in the first quarter valued at approximately $46,000. Renaissance Technologies LLC raised its holdings in Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the last quarter. Carnegie Investment Counsel raised its holdings in Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the period. 5.79% of the stock is currently owned by institutional investors and hedge funds.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.